New England Biolabs
New England Biolabs is a biotechnology company that develops, manufactures, and distributes reagents and tools for molecular biology, including restriction enzymes, polymerases, cloning kits, and next-generation sequencing reagents used by academic, pharmaceutical, and industrial researchers. It generates revenue by selling these products globally through direct sales, distributors, and e-commerce channels. The company also offers custom manufacturing and OEM services for life science and diagnostic companies.
- Revenue
- $450.0M
- Employees
- 1,800
- Founded
- 1974
- Headquarters
- Ipswich, United States of America
What 14 Arbolus experts think of New England Biolabs
NPS scores are strongly positive, with most experts rating NEB between 8 and 10. Renewal intent is robust, especially among influencers controlling significant budgets, indicating strong institutional confidence. Most users are in the late implementation stage, with 'more than one year' of usage dominating. Key themes from expert feedback highlight NEB's consistency, support tools, and product documentation as key strengths. Occasional price sensitivity is noted, but overall sentiment is driven by perceived superior value.Overall Customer Sentiment: Positive
Who reviewed New England Biolabs
- C-Suite 57% (8)
- Director 21% (3)
- Manager 21% (3)
Employer names and spend open in the full report, along with the other 11 customers.
Everything 14 customers told us about New England Biolabs.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
50 Net Promoter Score, from 14 scored reviews- Promoters 8
- Passives 5
- Detractors 1
Cumulative NPS by month
+0 over 5 months- Mar 8
- May 8
- Jul 8
- Aug 8
- Sep 8
Net Promoter Score across 1 reviews, accumulated up to each month. Category median 50 across 1 companies.
Praised
- Superior Technical Support and Documentation
- Reliability and Environmental Responsibility
- Unmatched Product Quality
- Enhancing Environmental Sustainability
Criticised
- Aggressive Competitor Pricing
- Potential AI Disruption by Competitors
- Switching for Workflow Integration
- Price Sensitivity
What customers say
Renewal intent
Plan to renew 75%Plan to renew, by seniority
- 75% 4 answers
- 50% 2 answers
- 100% 2 answers
- 8.8/10 Average score from customers who will renew
- 8/10 Average score from undecided customers
Report
For people who use New England Biolabs
Do you use New England Biolabs at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 14 customers of New England Biolabs have already contributed
Takes a few minutes. Your identity stays anonymous.